title: Risk of stent thrombosis after lower-extremity endovascular revascularization: which is the optimal antithrombotic therapy and is early strenuous exercise safe?
authors.forename: M
authors.initials: M
authors.lastname: Ambrosetti
authors.forename: M
authors.initials: M
authors.lastname: Tozzi
authors.forename: G
authors.initials: G
authors.lastname: Piffaretti
authors.forename: A
authors.initials: A
authors.lastname: Barosi
authors.forename: R
authors.initials: R
authors.lastname: Caronno
authors.forename: G
authors.initials: G
authors.lastname: Poggio
authors.forename: P
authors.initials: P
authors.lastname: Castelli
mesh_terms: D000800:Angioplasty, Balloon / Q000379:methods; D001157:Arterial Occlusive Diseases / Q000175:diagnosis / Q000628:therapy*; D019317:Evidence-Based Medicine; D005080:Exercise Test / Q000009:adverse effects; D005263:Femoral Artery / Q000473:pathology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D035002:Lower Extremity / Q000098:blood supply*; D011150:Popliteal Artery / Q000473:pathology; D012307:Risk Factors; D015607:Stents / Q000009:adverse effects*; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control*; D016909:Tibial Arteries / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents